Could a simple gas reduce lung damage in ventilator patients?
NCT ID NCT05559970
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving a gas sedative (isoflurane) instead of standard IV drugs could reduce the energy delivered to the lungs by the breathing machine in 40 ICU patients. The goal was to see if this approach might lower the risk of lung injury. The trial was small and only measured short-term changes, so more research is needed.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- isoflurane
- What this could lead to
- If it works, this could point toward a better sedation method that reduces lung injury and improves recovery for ICU patients on ventilators.
- What could go wrong
- This is a very small pilot study (40 patients) that only looks at short-term changes in lung mechanics, not long-term outcomes. The results may not apply to all ICU patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Nov 2022
- Finished
-
Apr 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patient with age \>18 years old; and 2. Patient who is admitted to the participating ICU; and 3. Patient who receives respiratory support with invasive mechanical ventilation via endotracheal tube \< 12 hours prior to inclusion with anticipated duration of \> 48 hours Exclusion Criteria: 1. Patient with history or suspected history of malignant hyperthermia 2. Patient with evident or suspected increased intracranial pressure 3. Patient with high severity of illness whose ICU survival is not expected 4. Patient who refuses or patient whose proxy refuses to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ICU are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok Noi, Bangkok, 10700, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI that refreshes ICU death risk every 6 hours put to the test
- Can a peptide drug shield the hearts of ICU patients?
- Could letting patients breathe on their own sooner protect their lungs?
- Can tilting a Patient's body toward the infection help them breathe free sooner?
- The hidden breath: how a mismatch between patient and machine may shape ARDS recovery
- Can a bedside ultrasound predict which septic shock patients will stop breathing on their own?